Heavy element enhanced synchrotron stereotactic radiotherapy as a promising brain tumour treatment

Physica Medica

Volumn 24, Issue 2, 2008, Pages 92-97

  Adam, J F ^a,b   Biston, M C ^a,d   Rousseau, J ^a   Boudou, C ^a   Charvet, A M ^a,b   Balosso, J ^a,b,c   Esteve F ^a,b,c   Elleaume, H ^a  

^a INSERM   (France)

^b UNIV GRENOBLE ALPES   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d CENTRE LÉON BÉRARD   (France)

Author keywords

Iodinated contrast agents; IUdR; Stereotactic radiotherapy; Synchrotron radiation

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; IOMEPROL; MANNITOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTINUOUS INFUSION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG DISTRIBUTION; GLIOMA; NONHUMAN; RADIATION DOSE; RAT; STEREOTACTIC TREATMENT; SYNCHROTRON RADIATION; X RAY;

RATTUS;

EID: 44649165580     PISSN: 11201797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejmp.2008.02.003     Document Type: Article

References (24)

1. Adam J.F., Biston M.C., Joubert A., Charvet A.M., Le Bas J.F., Estève F., et al. Enhanced delivery of iodine for synchrotron stereotactic radiotherapy by means of intracarotid injection and blood brain barrier disruption: quantitative iodine biodistribution studies and associated dosimetry. Int J Radiat Oncol Biol Phys 61 (2005) 1173-1182
2. Adam J.F., Joubert A., Biston M.C., Charvet A.M., Peoc'h M., Le Bas J.F., et al. Prolonged survival of Fischer rats bearing F98 glioma after iodine-enhanced synchrotron stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 64 (2006) 603-611
3. Biston M.C., Joubert A., Adam J.F., Elleaume H., Bohic S., Charvet A.M., et al. Cure of Fisher rats bearing radioresistant F98 glioma treated with cis-platinum and irradiated with monochromatic synchrotron X-rays. Cancer Res 64 (2004) 2317-2323
4. Corde S., Adam J.F., Biston M.C., Joubert A., Charvet A.M., Estève F., et al. Synchrotron radiation-based experimental determination of the optimal energy for cell radiotoxicity enhancement following photoelectric effect on stable iodinated compounds. Br J Cancer 91 (2004) 544-551
5. Estève F., Corde S., Elleaume H., Adam J.F., Joubert A., Charvet A.M., et al. Enhanced radio sensitivity with iodinated contrast agents using monochromatic synchrotron X-rays on human cancerous cells. Acad Radiol 9 (2002) S540-S543
6. Lorusso V., Luzzani F., Bertani F., Tirone P., and Dehaen C. Pharmacokinetics and tissue distribution of iomeprol in animals. Eur J Radiol 18 Suppl. 1 (1994) S13-S20
7. Berry S.E., and Kinsella T.J. Targeting DNA mismatch repair for radiosensitization. Semin Radiat Oncol 11 (2001) 300-315
8. Karnas S.J., Yu E., McGarry R.C., and Battista J.J. Optimal photon energies for IUdR K-edge radiosensitization with filtered X-ray and radioisotope sources. Phys Med Biol 44 (1999) 2537-2549
9. Barth R.F. Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J Neurooncol 36 (1998) 91-102
10. Adam J.F., Elleaume H., Joubert A., Biston M.C., Charvet A.M., Balosso J., et al. Synchrotron radiation therapy of malignant brain glioma loaded with an iodinated contrast agent: first trial on rats bearing F98 gliomas. Int J Radiat Oncol Biol Phys 57 (2003) 1413-1426
11. Boudou C., Balosso J., Esteve F., and Elleaume H. Monte Carlo dosimetry for synchrotron stereotactic radiotherapy of brain tumours. Phys Med Biol 50 20 (2005) 4841-4851
12. Rousseau J., Boudou C., Esteve F., and Elleaume H. Convection-enhanced delivery of an iodine tracer into rat brain for synchrotron stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 68 3 (2007) 943-951
13. Robar J.L., Riccio S.A., and Martin M.A. Tumour dose enhancement using modified megavoltage photon beams and contrast media. Phys Med Biol 47 (2002) 2433-2449
14. Barth R.F., Yang W., Rotaru J.H., Moeschberger M.L., Boesel C.P., Soloway A.H., et al. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine. Int J Radiat Oncol Biol Phys 47 (2000) 209-218
15. Boudou C., Biston M.C., Corde S., Adam J.F., Ferrero C., Estève F., et al. Synchrotron stereotactic radiotherapy: dosimetry by Fricke gel and Monte Carlo simulations. Phys Med Biol 49 22 (2004) 5135-5144
16. Boudou C., Troprès I., Rousseau J., Lamalle L., Adam J.F., Estève F., et al. Polymer gel dosimetry for synchrotron stereotactic radiotherapy and iodine dose-enhancement measurements. Phys Med Biol 52 16 (2007) 4881-4892
17. Karnas S.J., Moiseenko V.V., Yu E., Truong P., and Battista J.J. Monte Carlo simulations and measurement of DNA damage from X-ray-triggered auger cascades in iododeoxyuridine (IUdR). Radiat Environ Biophys 40 (2001) 199-206
18. 123IUdR correlates with experimental in vitro cell killing effectiveness. Radiat Prot Dosimetry 99 (2002) 81-82
19. Bernhardt P., Friedland W., and Paretzke H. The role of atomic inner shell relaxations for photon induced DNA damage. Radiat Environ Biophys 43 (2004) 77-84
20. 125I]iodo-2′-deoxyuridine in the radiotherapy of brain tumors in rats. J Nucl Med 39 (1998) 1148-1154
21. Harrington K.J., Syrigos K.N., Uster P.S., Zetter A., Lewanski C.R., Gullick W.J., et al. Targeted radiosensitisation by pegylated liposome-encapsulated 3′, 5′-O-dipalmitoyl 5-iodo-2′-deoxyuridine in a head and neck cancer xenograft model. Br J Cancer 91 (2004) 366-373
22. Rousseau J., Boudou C., Barth R.F., Balosso J., Estève F., and Elleaume H. Enhanced survival and cure of F98 glioma-bearing rats following intracerebral delivery of carboplatin in combination with photon irradiation. Clin Cancer Res 13 17 (2007) 5195-5201
23. 125I decays. Radiat Res 107 (1986) 163-171
24. Mairs R.J., Wideman C.L., Angerson W.J., Whateley T.L., Reza M.S., Reeves J.R., et al. Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat model. Br J Cancer 82 (2000) 74-80